Metastatic cancer

Common Name(s)

Metastatic cancer

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Metastatic cancer" returned 2858 free, full-text research articles on human participants. First 3 results:

Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer.
 

Author(s): N Takahashi, Y Yamada, K Furuta, Y Honma, S Iwasa, A Takashima, K Kato, T Hamaguchi, Y Shimada

Journal: Br. J. Cancer. 2014 May;110(11):2716-27.

 

Ligands of transmembrane receptor tyrosine kinases have important roles in cell proliferation, survival, migration and differentiation in solid tumours. We conducted this study to evaluate the relationship between concentration of serum ligands and prognosis of patients with metastatic ...

Last Updated: 28 May 2014

Go To URL
Severe infusion reactions to cetuximab occur within 1 h in patients with metastatic colorectal cancer: results of a nationwide, multicenter, prospective registry study of 2126 patients in Japan.
 

Author(s): Kensei Yamaguchi, Toshiaki Watanabe, Taroh Satoh, Megumi Ishiguro, Makiko Izawa, Shogo Inoshiri, Kenichi Sugihara, Yuh Sakata

Journal: Jpn. J. Clin. Oncol.. 2014 Jun;44(6):541-6.

 

Infusion reactions are common adverse reactions associated with antibody preparations. However, no studies have examined the time to onset of serious infusion reactions after administering cetuximab. We aimed to investigate the timing and severity of IRs affecting Japanese patients ...

Last Updated: 27 May 2014

Go To URL
Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER.
 

Author(s): D A Yardley, D Tripathy, A M Brufsky, H S Rugo, P A Kaufman, M Mayer, J Magidson, B Yoo, C Quah, M Ulcickas Yood

Journal: Br. J. Cancer. 2014 May;110(11):2756-64.

 

Data characterising long-term survivors (LTS) with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) are limited. This analysis describes LTS using registHER observational study data.

Last Updated: 28 May 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Metastatic cancer" returned 297 free, full-text review articles on human participants. First 3 results:

Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel.
 

Author(s): John M Fitzpatrick, Joaquim Bellmunt, Karim Fizazi, Axel Heidenreich, Cora N Sternberg, Bertrand Tombal, Antonio Alcaraz, Amit Bahl, Sergio Bracarda, Giuseppe Di Lorenzo, Eleni Efstathiou, Stephen P Finn, Sophie Fosså, Silke Gillessen, Pirkko-Liisa Kellokumpu-Lehtinen, Frédéric E Lecouvet, Stephane Oudard, Theo M de Reijke, Craig N Robson, Maria De Santis, Bostjan Seruga, Ronald de Wit

Journal: Eur. J. Cancer. 2014 Jun;50(9):1617-27.

 

The exponential growth of novel therapies for the treatment of metastatic castration-resistant prostate cancer (mCRPC) over the last decade has created an acute need for education and guidance of clinicians regarding optimal strategies for patient management. A multidisciplinary panel ...

Last Updated: 20 May 2014

Go To URL
Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients.
 

Author(s): Giuseppe Aprile, Stefania Eufemia Lutrino, Laura Ferrari, Mariaelena Casagrande, Marta Bonotto, Elena Ongaro, Fabio Puglisi

Journal: World J. Gastroenterol.. 2013 Dec;19(46):8474-88.

 

Colorectal cancer (CRC) is a significant health problem, with around 1 million new cases and 500000 deaths every year worldwide. Over the last two decades, the use of novel therapies and more complex treatment strategies have contributed to progressively increase the median survival ...

Last Updated: 31 Dec 2013

Go To URL
Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers.
 

Author(s): C M Gaeta, J L Vercher-Conejero, A C Sher, A Kohan, C Rubbert, N Avril

Journal: Q J Nucl Med Mol Imaging. 2013 Dec;57(4):352-66.

 

Primary breast cancer often displays only moderately increased glucose metabolism resulting in a low sensitivity of positron emission tomography (PET) using [F-18]fluorodeoxyglucose (FDG) in detecting small breast carcinomas, locoregional micrometastases and non-enlarged tumor infiltrated ...

Last Updated: 10 Dec 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)
 

Status: Not yet recruiting

Condition Summary: Breast Cancer; Lung Cancer; Recurrent Brain Metastases; Progressive Brain Metastases

 

Last Updated: 17 Jun 2014

Go to URL
Short Course Radiotherapy and mFOLFOX6 With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis
 

Status: Recruiting

Condition Summary: Rectal Cancer; Liver Metastasis; Lung Metastasis

 

Last Updated: 14 Aug 2013

Go to URL
Aerosol IL-2 for Pulmonary Metastases
 

Status: Recruiting

Condition Summary: Sarcoma; Solid Tumors; Pulmonary Metastases; Lung Metastases; Osteosarcomas; Ewing Sarcoma

 

Last Updated: 11 Jul 2014

Go to URL